Valuation: DiaSorin S.p.A.

Market Cap 3.7B 4.23B 3.4B 3.17B 6.01B 403B 6.1B 40.82B 15.87B 198B 15.88B 15.54B 683B P/E 2026 *
20.3x
P/E 2027 * 17.8x
Enterprise Value 4.37B 5B 4.02B 3.75B 7.11B 476B 7.21B 48.25B 18.76B 234B 18.78B 18.38B 807B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.25x
Free-Float
37.17%
Yield 2026 *
1.87%
Yield 2027 * 1.95%
1 day+0.61%
1 week+2.14%
Current month+3.01%
1 month+3.78%
3 months+13.20%
6 months+2.05%
Current year+1.72%
1 week 67.54
Extreme 67.54
70.5
1 month 62.96
Extreme 62.96
72.46
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 2007-03-25
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2016-04-27
Director/Board Member 63 2007-03-25
Chairman 57 2022-04-28
Date Insider Type Main position Quantity % Market Cap.
03-23Buy

Chief Executive Officer

9,211 0.0165%
01-27Buy

Chief Executive Officer

7,500 0.0134%
01-07Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+2.14%-22.74%-25.43% 4.23B
-1.63%+12.57%+232.63%+375.33% 22.27B
-1.27%-2.18%-41.43%-25.52% 9.4B
+0.85%+0.08%+36.65%+31.18% 7.15B
-2.40%-1.08%-31.05% - 5.17B
+0.23%+4.51%-19.64%-25.14% 5.13B
-0.10%+6.15%+199.85%-31.25% 4.95B
-1.07%-0.09%+81.53%+87.15% 4.1B
+2.89%+8.01%-17.54%-41.07% 2.61B
+11.62%+63.74%-24.25%+188.93% 1.59B
Average +0.97%+7.64%+39.40%+59.35% 6.66B
Weighted average by Cap. -0.44%+7.71%+89.10%+138.38%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.13B 1.05B 1.99B 134B 2.02B 13.54B 5.26B 65.68B 5.27B 5.15B 226B 1.31B 1.49B 1.2B 1.12B 2.12B 142B 2.16B 14.41B 5.6B 69.95B 5.61B 5.49B 241B
Net income 183M 209M 168M 157M 297M 19.9B 301M 2.02B 784M 9.78B 784M 768M 33.71B 206M 236M 190M 177M 335M 22.47B 340M 2.28B 885M 11.04B 886M 867M 38.06B
Net Debt 674M 771M 619M 577M 1.1B 73.41B 1.11B 7.44B 2.89B 36.09B 2.89B 2.83B 124B 543M 621M 499M 465M 882M 59.14B 896M 5.99B 2.33B 29.07B 2.33B 2.28B 100B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
26-07-03 €69.80 +0.61% 136,188
26-07-02 €69.38 -0.54% 128,782
26-07-01 €69.76 +2.95% 212,969
26-06-30 €67.76 -3.14% 238,260
26-06-29 €69.96 +2.37% 331,777
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
69.80EUR
Average target price
70.52EUR
Spread / Average Target
+1.03%

Quarterly revenue - Rate of surprise